Hanmi wins Viagra’s design trials

A Hanmi Pharm’s erectile dysfunction treatment, Palpal was finally confirmed not to infringe the Viagra’s trademark right.

On the 18^th, the 4^th Civil Division, Seoul High Court, dismissed the plaintiff’s appeal in the remand after reversal of the trial against infringement of the design right, filed by Pfizer against Hanmi Pharm.

In the past, the Supreme Court returned the case to the Seoul H...